Clinical trials of zotarolimus ES
Clinical trials of zotarolimus ES and meta-analysis are available for the following clinical conditions:
acute myocardial infarction
acute myocardial infarction, myocardial revascularization, all type of patients
zotarolimus ES vs paclitaxel ES :
ZEST AMI (vs PES), 2009
-
zotarolimus ES vs sirolimus ES :
ZEST AMI (vs SES), 2009
-
acute myocardial infarction, PCI, all type of patients
zotarolimus ES vs paclitaxel ES :
ZEST AMI (vs PES), 2009
-
zotarolimus ES vs sirolimus ES :
ZEST AMI (vs SES), 2009
-
coronary artery disease
coronary artery disease, myocardial revascularization, all type of patient
zotarolimus ES vs bare-metal stent :
ENDEAVOR II, 2006
-
zotarolimus ES vs everolimus ES :
RESOLUTE, 2010
-
zotarolimus ES vs paclitaxel ES :
ENDEAVOR IV, 2009
-
ZoMaxx phase 2, 0
-
ZoMaxx phase 3, 2007
-
ZEST AMI (vs PES), 2009
-
ZEST (vs PES), 2009
-
zotarolimus ES vs sirolimus ES :
DIABEDES IV, 0
-
ENDEAVOR III, 2006
-
PROTECT, 0
-
PRISON III, 2007
-
ZEST (vs SES), 2009
-
ZEST AMI (vs SES), 2009
-
coronary artery disease, myocardial revascularization, diabetic patients
zotarolimus ES vs sirolimus ES :
DIABEDES IV, 0
-
coronary artery disease, revascularization with drug eluting stent, all type of patients
zotarolimus ES vs bare-metal stent :
ENDEAVOR II, 2006
-
zotarolimus ES vs everolimus ES :
RESOLUTE, 2010
-
zotarolimus ES vs paclitaxel ES :
ENDEAVOR IV, 2009
-
ZoMaxx phase 2, 0
-
ZoMaxx phase 3, 2007
-
ZEST AMI (vs PES), 2009
-
ZEST (vs PES), 2009
-
zotarolimus ES vs sirolimus ES :
DIABEDES IV, 0
-
ENDEAVOR III, 2006
-
PROTECT, 0
-
PRISON III, 2007
-
ZEST (vs SES), 2009
-
SORT-OUT-3, 2010
-
coronary artery disease, revascularization with drug eluting stent, diabetic patients
zotarolimus ES vs sirolimus ES :
DIABEDES IV, 0
-
coronary artery disease, revascularization with drug eluting stent, acute myocardial infarction
zotarolimus ES vs paclitaxel ES :
ZEST AMI (vs PES), 2009
-
zotarolimus ES vs sirolimus ES :
ZEST AMI (vs SES), 2009
-
SORT-OUT-3, 2010
-
coronary artery disease, revascularization with drug eluting stent, unparticular patients
zotarolimus ES vs bare-metal stent :
ENDEAVOR II, 2006
-
zotarolimus ES vs everolimus ES :
RESOLUTE, 2010
-
zotarolimus ES vs paclitaxel ES :
ZEST (vs PES), 2009
-
ENDEAVOR IV, 2009
-
ZoMaxx phase 2, 0
-
ZoMaxx phase 3, 2007
-
zotarolimus ES vs sirolimus ES :
ENDEAVOR III, 2006
-
PROTECT, 0
-
ZEST (vs SES), 2009
-
coronary artery disease, revascularization with drug eluting stent, total occlusion
zotarolimus ES vs sirolimus ES :
PRISON III, 2007
-
stable angina
stable angina, myocardial revascularization, all type of patient
zotarolimus ES vs bare-metal stent :
ENDEAVOR II, 2006
-
zotarolimus ES vs everolimus ES :
RESOLUTE, 2010
-
zotarolimus ES vs paclitaxel ES :
ENDEAVOR IV, 2009
-
ZoMaxx phase 2, 0
-
ZoMaxx phase 3, 2007
-
zotarolimus ES vs sirolimus ES :
DIABEDES IV, 0
-
ENDEAVOR III, 2006
-
PROTECT, 0
-
PRISON III, 2007
-
ZEST (vs SES), 2009
-
Entry terms:
See also relatic topics:
Search zotarolimus ES clinical trials in
Pubmed
Search zotarolimus ES clinical trials in
ClinicalTrials.gov
Search zotarolimus ES clinical trials in
Wikipedia
Search zotarolimus ES in
drugs.com
browse_trt3
|